Literature DB >> 940711

Propranolol and exercise as a screening test for growth hormone deficiency.

B S Shanis, T Moshang.   

Abstract

There is a need for a safe, inexpensive, and reliable screening test for growth hormone (GH) reserve. Exercise has been utilized for this purpose but false-negative responses (inadequate GH release in non-GH-deficient patients) has limited the effectiveness of this stimulus as a screening test. Beta-adrenergic blockade (propranolol) was used to enhance the effect of exercise on GH release. Thirty-two non-GH-deficient children and five GH-deficient children were evaluated. All of the non-GH-deficient children responded to propranolol and exercise with serum GH levels exceeding 7 ng/ml. The peak serum GH levels in the five GH-deficient patients did not exceed 4 ng/ml. Propranolol and exercise appears to be an effective screening test for GH function.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 940711

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Effects of cardioselective and non-selective beta-adrenoceptor blockade on glycogenolysis, lipolysis and growth hormone secretion.

Authors:  S Raptis
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

2.  Effects of cardioselective and non-cardioselective beta-blockade on adrenaline-induced metabolic and cardiovascular responses in man.

Authors:  S Raptis; J Rosenthal; D Welzel; S Moulopoulos
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

3.  Plasma and urinary GH following a standardized exercise protocol to assess GH production in short children.

Authors:  A Sartorio; E Palmieri; V Vangeli; G Conte; M Narici; G Faglia
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

4.  Clonidine is a better test for growth hormone deficiency than insulin hypoglycaemia.

Authors:  N C Fraser; J Seth; N S Brown
Journal:  Arch Dis Child       Date:  1983-05       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.